---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-077144"
form_type: "8-K/A"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2024-09-10T23:59:59+00:00"
generated_at: "2026-05-31T05:42:52.330630+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics corrects reverse stock split effective time to Sept 11, 2024

## Summary
- Certificate of Correction filed to set 1-for-30 reverse split effective 12:01 a.m. ET Sept 11, 2024.
- Charter amendment reduces authorized shares from 750.5M to 250.5M, effective Sept 9 at 9:30 a.m. ET.
- 2021 Equity Incentive Plan shares increased from 2,168,330 to 10,594,876 approved at Annual Meeting.
- All 7 stockholder proposals passed at Sept 3 Annual Meeting, including director elections and auditor ratification.

## SEC filing metadata
- accession: 0001213900-24-077144
- form_type: 8-K/A
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2024-09-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390024077144/0001213900-24-077144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390024077144/ea0214018-8ka1_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-077144
- JSON: https://secwatch.observer/filing/0001213900-24-077144.json
- Plain text: https://secwatch.observer/filing/0001213900-24-077144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.